Mike Stratton
Direktor/Vorstandsmitglied bei Wellcome Trust Sanger Institute
Profil
Mike Stratton is the founder of Quotient Therapeutics Ltd., which was founded in 2022.
He is currently the Director at Wellcome Trust Sanger Institute.
Aktive Positionen von Mike Stratton
Unternehmen | Position | Beginn |
---|---|---|
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Mike Stratton
Unternehmen | Position | Ende |
---|
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Health Technology |